FindTrial
Sign In

EFFECT OF POLYUNSATURATED FATTY ACIDS ON GROWTH OF PRETERM NEONATES

TO STUDY THE EFFECT OF ENTERAL SUPPLEMENTATION WITH POLYUNSATURATED FATTY ACIDS ON GROWTH OF PRETERM NEONATES: A RANDOMISED CONTROL TRIAL - PUFA_2020

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030420
Enrollment
120
Registered
2021-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: POLYUNSATURATED FATTY ACID (PUFA) SUPPLEMENTATION: PATIENTS WILL RECEIVE POLYUNSATURATED FATTY ACID (PUFA) SUPPLEMENTATION IN FORM OF DROPS 1.5ML DAILY (EACH ml CONTAINING DHA:100mg AND

Sponsors

Dr RUSHIKESH GAVHANE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All preterm ( <37weeks) neonates admitted in Neonanatology Unit receiving minimum 60ml/kg/day enteral feeds

Exclusion criteria

Exclusion criteria: 1. Seriously ill (Severe Sepsis, Hypotension, Interventricular hemorrhage) 2. Gastrointestinal malformations 3. Preterm neonates receiving 4. Congenital Heart Disease 5. Bronchopulmonary Dysplasia 6. Preterm fed with formula containing Polyunsaturated Fatty Acids

Design outcomes

Primary

MeasureTime frame
To study the effect of enteral supplementation of polyunsaturated fatty acids on physical growth (Weight, Length and Head circumference) of preterm neonates till corrected 6 months of ageTimepoint: 6 months—

Secondary

MeasureTime frame
Developmental Assessmentof the preterm neonates at Expected Term, Corrected 3 Months and 6 Months of age.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDR TRUPTI GUJARATI JOSHI

GMCH, Aurangabad

drtruptijoshi@gmail.com9823900642

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026